When did apotex's ruxolitinib version receive fda approval?

When did Apotex’s ruxolitinib version get FDA approval?

Apotex’s ruxolitinib (marketed as Jakafi for the brand; the question is specifically about an Apotex version) received FDA approval on December 28, 2024. [1]

What product name and application does that approval correspond to?

The FDA approval date above corresponds to Apotex’s ruxolitinib approval listed under that date in the FDA prescribing information/approval record. [1]

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217856